REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $906,749 | +14.9% | 75,062 | +0.7% | 0.00% | – |
| Q2 2023 | $788,866 | +6.7% | 74,562 | -0.7% | 0.00% | – |
| Q1 2023 | $739,004 | -33.1% | 75,102 | 0.0% | 0.00% | – |
| Q4 2022 | $1,104,751 | +23.4% | 75,102 | +1.7% | 0.00% | – |
| Q3 2022 | $895,000 | -12.6% | 73,842 | +0.8% | 0.00% | – |
| Q2 2022 | $1,024,000 | +11.5% | 73,242 | +13.6% | 0.00% | – |
| Q1 2022 | $918,000 | -32.1% | 64,469 | +0.6% | 0.00% | – |
| Q4 2021 | $1,351,000 | +46.8% | 64,109 | +82.9% | 0.00% | – |
| Q3 2021 | $920,000 | -12.6% | 35,044 | +3.8% | 0.00% | – |
| Q2 2021 | $1,053,000 | +1.2% | 33,774 | -0.4% | 0.00% | – |
| Q1 2021 | $1,041,000 | -3.3% | 33,908 | +7.9% | 0.00% | – |
| Q4 2020 | $1,077,000 | – | 31,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $28,001,631 | 33.22% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $23,727,089 | 11.64% |
| CHI Advisors LLC | 2,998,734 | $31,726,606 | 9.63% |
| MPM BioImpact LLC | 1,639,849 | $17,349,602 | 3.49% |
| BVF INC/IL | 8,291,988 | $87,729,233 | 2.44% |
| Deep Track Capital, LP | 2,727,606 | $28,858,071 | 1.34% |
| Redmile Group, LLC | 2,428,335 | $25,691,784 | 0.99% |
| HighVista Strategies LLC | 165,173 | $1,747,530 | 0.80% |
| Orbimed Advisors | 3,322,488 | $35,151,923 | 0.64% |
| DIFESA CAPITAL MANAGEMENT, LP | 15,416 | $163,101 | 0.43% |